Efficacy of a Transforming Growth Factor β2 Containing Nutritional Support Formula in a Murine Model of Inflammatory Bowel Disease

REFERENCES

• Verhoef MJ, Sutherland RL: Outpatient healthcare utilization of patients with inflammatory bowel disease. Dig Dis Sci35 :1276– 1280,1990 .
   PubMedGoogle Scholar
• Moser G, Tillinger W, Sachs G, Maier-Dobersberger T, Wyatt J, Vogelsang H, Lochs H, Gangl A: Relationship between the use of unconventional therapies and disease-related concerns. J Psychosom Res40 :503– 509,1996 .
   PubMed Web of Science ®Google Scholar
• Hilsden RJ, Scott CM, Verhoef MJ: Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol93 :697– 701,1998 .
   PubMed Web of Science ®Google Scholar
• Haas L, McClain CJ, Varilek G: Complementary and alternative medicine and gastrointestinal diseases. Curr Opinion Gastroenterol16 :188– 196,2000 .
   PubMedGoogle Scholar
• McClain CJ, Dryden G, Krueger K: Complementary and alternative medicine in gastroenterology. Yamada T (ed): “Textbook of Gastroenterology,” 4th ed, vol 1. Philadelphia: Lippincott Williams & Wilkins, pp1135– 1146,2003 .
   Google Scholar
• Graham TO, Kandil HM: Nutritional factors in inflammatory bowel disease. Gastroenterol Clin North Am31 :203– 218,2002 .
   PubMed Web of Science ®Google Scholar
• Marek A, Brodzicki J, Berek A, Korzon M: TGF-β (transforming growth factor-β) in chronic inflammatory conditions—a new diagnostic and prognostic marker? Med Sci Monit8 :145– 151,2002 .
   Web of Science ®Google Scholar
• Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA: A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol166 :7282– 7289,2001 .
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Kovar H, Majdic O, Holter W: Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. J Immunol156 :459– 464,1996 .
   PubMed Web of Science ®Google Scholar
• Ciacci C, Lind SE, Podolsky DK: Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology105 :93– 101,1993 .
   PubMed Web of Science ®Google Scholar
• DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC: Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol34 :385– 396,2002 .
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Doria MI, Sedghi S, Kanofsky JR, Hecht D, Holmes EW, Ibrahim C, List T, Urban G, Gaginella T, et al.: Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen species. J Lab Clin Med120 :778– 791,1992 .
   PubMedGoogle Scholar
• Rogler G, Andus T: Cytokines in IBD. Word J Surg22 :382– 389,1998 .
   PubMed Web of Science ®Google Scholar
• Lee YJ, Han Y, Lu HT, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN: TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol158 :2065– 2075,1997 .
   PubMed Web of Science ®Google Scholar
• Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P, Donnet-Hughes A, MacDonald TT, Walker-Smith JA: Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharmacol Ther14 :281– 289,2000 .
   PubMed Web of Science ®Google Scholar
• Rennick DM, Fort MM: Lessons from genetically engineered animal models. XII. IL-10-deficient IL-10(−/−) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol278 :G829– G823,2000 .
   PubMedGoogle Scholar
• Richie JP, Lang CA: The determination of glutathione, cyst(e)ine, and other thiols and disulfides in biological samples using high performance liquid chromatography with dual electrochemical detection. Anal Biochem163 :9– 15,1987 .
   PubMed Web of Science ®Google Scholar
• Chen TS, Richie JP, Lang CA: Life span profiles of glutathione and acetaminophen detoxification. Drug Metab Dispos18 :882– 887,1990 .
   PubMedGoogle Scholar
• Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer R-JM: Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr67 :919– 926,1998 .
   PubMed Web of Science ®Google Scholar
• Griffiths AM: Enteral nutrition in children. In Bistrian BR, Walker-Smith JA (eds): “Inflammatory Bowel Disease,” Nestle Nutrition Workshop Series Clinical & Performance Programme, pp171– 186,1999 .
   Google Scholar
• Alpers DH: Use of macro- and micronutrients for nutrition support in inflammatory bowel disease. In Bistrian BR, Walker-Smith JA (eds): “Inflammatory Bowel Disease,” Nestle Nutrition Workshop Series Clinical & Performance Programme, vol. 2, pp155– 170,1999 .
   Google Scholar
• Jeejeebhoy KN. Nutrition versus drug therapy. In Bistrian BR, Walker-Smith JA (eds): “Inflammatory Bowel Disease,” Nestle Nutrition Workshop Series Clinical & Performance Programme, vol. 2, pp139– 154,1999 .
   Google Scholar
• Duerksen DR, Nehra V, Bistrian BR, Blackburn GL: Appropriate nutritional support in acute and complicated Crohn’s disease. Nutrition14 :462– 465,1998 .
   PubMed Web of Science ®Google Scholar
• O’Sullivan MA, O’Morain CA: Nutritional therapy in Crohn’s disease. Inflamm Bowel Dis4 :45– 53,1998 .
   PubMedGoogle Scholar
• Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR: Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology108 :1056– 1067,1995 .
   PubMed Web of Science ®Google Scholar
• Heuschkel RB, Menache CC, Megerian JT, Baird AE: Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr31 :8– 15,2000 .
   PubMed Web of Science ®Google Scholar
• Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino Jr MA: Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med166 :571– 576,1987 .
   PubMed Web of Science ®Google Scholar
• Fiocchi C: TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation. J Clin Invest108 :523– 526,2001 .
   PubMed Web of Science ®Google Scholar
• Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, Jung HY, Green J, Kim SJ: Loss of transforming growth factor beta signaling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut49 :190– 198,2001 .
   PubMedGoogle Scholar
• Fuss IJ, Boirivant M, Lacy B, Strober W: The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol168 :900– 908,2002 .
   PubMed Web of Science ®Google Scholar
• Hibi T, Ogata H, Sakuraba A: Animal models of inflammatory bowel disease. J Gastroenterol37 :409– 417,2002 .
   PubMed Web of Science ®Google Scholar
• Song X, Zeng L, Pilo CM, Zagorski J, Wahl SM: Inhibition of bacterial cell wall-induced leukocyte recruitment and hepatic granuloma formation by TGF-beta gene transfer. J Immunol163 :4020– 4026,1999 .
   PubMedGoogle Scholar